UMC for technical assistance and Dr. Hongkai Zhang from 548-04-9 chemical information Jiuxianqiao Hospital for her aid in immunohistochemistry. Author Contributions Conceived and created the experiments: JY JXL. Performed the experiments: HYJ ZYZ DLZ BW YMY ML HXY BG ZL. Analyzed the information: LD FW WS CZL YNM JWZ HLZ. Wrote the paper: JY YNM HYJ WB. ten MicroRNA-10a in Gastric Cancer References 1. Mathers CD, Shibuya K, Boschi-Pinto C, Lopez AD, Murray CJ Naringin Global and regional estimates of cancer mortality and incidence by website: I. Application of regional cancer survival model to estimate cancer mortality distribution by website. BMC Cancer 2: 36. 2. Lewis BP, Burge CB, Bartel DP Conserved seed pairing, normally flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 1520. 3. Wang R, Wang ZX, Yang JS, Pan X, De W, et al. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14. Oncogene 30: 26442658. four. Deng M, Tang H, Zhou Y, Zhou M, Xiong W, et al. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci 124: 29973005. 5. Wu ZS, Wu Q, Wang CQ, Wang XN, Huang J, et al. miR-340 inhibition of breast cancer cell migration and invasion via targeting of oncoprotein cMet. Cancer 117: 28422852. 6. Zhang T, Wang Q, Zhao D, Cui Y, Cao B, et al. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci 121: 437447. 7. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, et al. Complete MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 11291139. 8. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47: 12231232. 9. Extended MJ, Wu FX, Li P, Liu M, Li X, et al. MicroRNA-10a targets CHL1 and promotes cell development, migration and invasion in human cervical cancer cells. Cancer Lett 324: 186196. 10. Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, Garate L, Bandres E, et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res six: 18301840. 11. Egger G, Liang G, Aparicio A, Jones PA Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457463. 12. Kim K, Lee HC, Park JL, Kim M, Kim SY, et 18325633 al. Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 6: 740751. 13. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, et al. Epigenetic silencing of miR-137 is definitely an early event in colorectal carcinogenesis. Cancer Res 70: 66096618. 14. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J Exploration of tumorsuppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 20942105. 15. Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H Hypermethylation of let-7a-3 in epithelial ovarian cancer is related to low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 67: 10117 10122. 16. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with sophisticated clinical stage, lymph node metastasis and patient poor prognosis. RNA 14: 23482360. 17. Ohuchida K, Mizumoto K, Lin C, Yamaguchi H, Ohtsuka T, et al. MicroRNA-10a is Overexpressed in Human Pancreatic Cancer and Involved in Its Invasiveness Partially vi.UMC for technical help and Dr. Hongkai Zhang from Jiuxianqiao Hospital for her assist in immunohistochemistry. Author Contributions Conceived and designed the experiments: JY JXL. Performed the experiments: HYJ ZYZ DLZ BW YMY ML HXY BG ZL. Analyzed the data: LD FW WS CZL YNM JWZ HLZ. Wrote the paper: JY YNM HYJ WB. ten MicroRNA-10a in Gastric Cancer References 1. Mathers CD, Shibuya K, Boschi-Pinto C, Lopez AD, Murray CJ International and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by web site. BMC Cancer two: 36. two. Lewis BP, Burge CB, Bartel DP Conserved seed pairing, usually flanked by adenosines, indicates that a huge number of human genes are microRNA targets. Cell 120: 1520. 3. Wang R, Wang ZX, Yang JS, Pan X, De W, et al. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14. Oncogene 30: 26442658. 4. Deng M, Tang H, Zhou Y, Zhou M, Xiong W, et al. miR-216b suppresses tumor development and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci 124: 29973005. five. Wu ZS, Wu Q, Wang CQ, Wang XN, Huang J, et al. miR-340 inhibition of breast cancer cell migration and invasion via targeting of oncoprotein cMet. Cancer 117: 28422852. six. Zhang T, Wang Q, Zhao D, Cui Y, Cao B, et al. The oncogenetic function of microRNA-31 as a possible biomarker in oesophageal squamous cell carcinoma. Clin Sci 121: 437447. 7. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, et al. Extensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 11291139. eight. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47: 12231232. 9. Lengthy MJ, Wu FX, Li P, Liu M, Li X, et al. MicroRNA-10a targets CHL1 and promotes cell development, migration and invasion in human cervical cancer cells. Cancer Lett 324: 186196. 10. Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, Garate L, Bandres E, et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res six: 18301840. 11. Egger G, Liang G, Aparicio A, Jones PA Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457463. 12. Kim K, Lee HC, Park JL, Kim M, Kim SY, et 18325633 al. Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 6: 740751. 13. Balaguer F, Hyperlink A, Lozano JJ, Cuatrecasas M, Nagasaka T, et al. Epigenetic silencing of miR-137 is an early occasion in colorectal carcinogenesis. Cancer Res 70: 66096618. 14. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J Exploration of tumorsuppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 20942105. 15. Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H Hypermethylation of let-7a-3 in epithelial ovarian cancer is related to low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 67: 10117 10122. 16. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, et al. MicroRNA miR-21 overexpression in human breast cancer is linked to sophisticated clinical stage, lymph node metastasis and patient poor prognosis. RNA 14: 23482360. 17. Ohuchida K, Mizumoto K, Lin C, Yamaguchi H, Ohtsuka T, et al. MicroRNA-10a is Overexpressed in Human Pancreatic Cancer and Involved in Its Invasiveness Partially vi.
